Geoffrey C. Gillespie - 12 Sep 2023 Form 3 Insider Report for Orthofix Medical Inc. (OFIX)

Role
VP, Controller, Interim CFO
Signature
/s/ Geoffrey C Gillespie
Issuer symbol
OFIX
Transactions as of
12 Sep 2023
Transactions value $
$0
Form type
3
Filing time
18 Sep 2023, 17:18:17 UTC
Next filing
17 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OFIX Common Stock 9.74K 12 Sep 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OFIX Employee Stock Option (Right to Buy) 12 Sep 2023 Common Stock 11.2K $20.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consist of unvested restricted stock units, of which, 100 units will vest on December 15, 2023, 101 units will vest on December 15, 2024, 291 units will vest on April 1, 2024, 292 units will vest on April 1, 2025, 615 units will vest on February 1, 2024, 615 units will vest on February 1, 2025, 615 units will vest on February 1, 2026, 1,551 units will vest on January 5, 2024, 1,552 units will vest on January 5, 2025, 1,552 units will vest on January 5, 2026, and 2,459 units will vest on January 31, 2025.
F2 The options were granted on January 5, 2023 (the "Grant Date") and will vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date.